Andrew John Hugh MacIntyre Sims

CIK: 0001802687

Transaction Breakdown

Open Market Buys (P)2 (9.1%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)10 (45.5%)

Derivative conversions

Awards (A)10 (45.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CNSY

CERENOME, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (22 total)

CNSY
CERENOME, INC.
Oct 1, 2026
Exercise(M)
Direct
1.2K shares-
CNSY
CERENOME, INC.
Oct 1, 2026
Exercise(M)
Direct
287 shares-
CNSY
CERENOME, INC.
Oct 1, 2026
Exercise(M)
Direct
1.5K shares-
PSTV
PLUS THERAPEUTICS, INC.
Jul 1, 2026
Exercise(M)
Direct
1.2K shares-
PSTV
PLUS THERAPEUTICS, INC.
Jul 1, 2026
Exercise(M)
Direct
1.5K shares-
PSTV
PLUS THERAPEUTICS, INC.
Jul 1, 2026
Exercise(M)
Direct
287 shares-
PSTV
PLUS THERAPEUTICS, INC.
May 14, 2026
Award(A)
Restricted Stock Units
Direct
3.4K shares-
PSTV
PLUS THERAPEUTICS, INC.
May 14, 2026
Award(A)
Stock Option (Right to Buy)
Direct
3.4K shares-
PSTV
PLUS THERAPEUTICS, INC.
Apr 1, 2026
Exercise(M)
Direct
38.3K shares-
PSTV
PLUS THERAPEUTICS, INC.
Apr 1, 2026
Exercise(M)
Direct
29.1K shares-
PSTV
PLUS THERAPEUTICS, INC.
Feb 25, 2026
Award(A)
Stock Option (Right to Buy)
Direct
349.5K shares-
PSTV
PLUS THERAPEUTICS, INC.
Feb 25, 2026
Award(A)
Restricted Stock Units
Direct
349.5K shares-
PSTV
PLUS THERAPEUTICS, INC.
Jan 1, 2026
Exercise(M)
Direct
38.3K shares-
PSTV
PLUS THERAPEUTICS, INC.
Nov 4, 2025
Purchase(P)
Direct
20K shares at avg. $0.51$10K
PSTV
PLUS THERAPEUTICS, INC.
Oct 1, 2025
Exercise(M)
Direct
38.3K shares-
PSTV
PLUS THERAPEUTICS, INC.
Aug 13, 2025
Award(A)
Stock Option (Right to Buy)
Direct
1.4M shares-
PSTV
PLUS THERAPEUTICS, INC.
Aug 13, 2025
Award(A)
Restricted Stock Units
Direct
459.9K shares-
PSTV
PLUS THERAPEUTICS, INC.
Aug 13, 2025
Award(A)
Restricted Stock Units
Direct
459.9K shares-
PSTV
PLUS THERAPEUTICS, INC.
Aug 13, 2025
Award(A)
Stock Option (Right to Buy)
Direct
1.4M shares-
PSTV
PLUS THERAPEUTICS, INC.
Feb 18, 2025
Award(A)
Stock Option (Right to Buy)
Direct
60K shares-
PSTV
PLUS THERAPEUTICS, INC.
Sep 11, 2024
Award(A)
Stock Option (Right to Buy)
Direct
46.1K shares-
PSTV
PLUS THERAPEUTICS, INC.
Sep 10, 2024
Purchase(P)
Direct
4.1K shares at avg. $1.27$5K

		Type	Shares	Price		Ownership
Oct 1, 2026	CNSY CERENOME, INC.	Exercise(M)	1,165	-	$0	Direct
Oct 1, 2026	CNSY CERENOME, INC.	Exercise(M)	287	-	$0	Direct
Oct 1, 2026	CNSY CERENOME, INC.	Exercise(M)	1,533	-	$0	Direct
Jul 1, 2026	PSTV PLUS THERAPEUTICS, INC.	Exercise(M)	1,165	-	$0	Direct
Jul 1, 2026	PSTV PLUS THERAPEUTICS, INC.	Exercise(M)	1,533	-	$0	Direct
Jul 1, 2026	PSTV PLUS THERAPEUTICS, INC.	Exercise(M)	287	-	$0	Direct
May 14, 2026	PSTV PLUS THERAPEUTICS, INC.	Award(A) Restricted Stock Units	3,443	-	-	Direct
May 14, 2026	PSTV PLUS THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	3,443	-	-	Direct
Apr 1, 2026	PSTV PLUS THERAPEUTICS, INC.	Exercise(M)	38,323	-	$0	Direct
Apr 1, 2026	PSTV PLUS THERAPEUTICS, INC.	Exercise(M)	29,129	-	$0	Direct
Feb 25, 2026	PSTV PLUS THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	349,541	-	-	Direct
Feb 25, 2026	PSTV PLUS THERAPEUTICS, INC.	Award(A) Restricted Stock Units	349,542	-	-	Direct
Jan 1, 2026	PSTV PLUS THERAPEUTICS, INC.	Exercise(M)	38,323	-	$0	Direct
Nov 4, 2025	PSTV PLUS THERAPEUTICS, INC.	Purchase(P)	20,000	$0.51	$10,200	Direct
Oct 1, 2025	PSTV PLUS THERAPEUTICS, INC.	Exercise(M)	38,323	-	-	Direct
Aug 13, 2025	PSTV PLUS THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	1,379,636	-	-	Direct
Aug 13, 2025	PSTV PLUS THERAPEUTICS, INC.	Award(A) Restricted Stock Units	459,878	-	-	Direct
Aug 13, 2025	PSTV PLUS THERAPEUTICS, INC.	Award(A) Restricted Stock Units	459,878	-	-	Direct
Aug 13, 2025	PSTV PLUS THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	1,379,636	-	-	Direct
Feb 18, 2025	PSTV PLUS THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	60,020	-	-	Direct
Sep 11, 2024	PSTV PLUS THERAPEUTICS, INC.	Award(A) Stock Option (Right to Buy)	46,074	-	-	Direct
Sep 10, 2024	PSTV PLUS THERAPEUTICS, INC.	Purchase(P)	4,098	$1.27	$5,204	Direct

1-22 of 22 transactions

About Sims Andrew John Hugh MacIntyre

Sims Andrew John Hugh MacIntyre (SEC CIK 0001802687) files insider reports with the SEC as Chief Financial Officer of CERENOME, INC. (CNSY).

Signal8 holds 13 ownership filings by Sims Andrew John Hugh MacIntyre, all Form 4s, filed between Sep 11, 2024 and Oct 1, 2026. Those filings report 22 transactions, from Sep 10, 2024 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Sims Andrew John Hugh MacIntyre's filings is in HOUSTON, TX.

Recent filings by Sims Andrew John Hugh MacIntyre

Oct 1, 2026: Option exercises of CNSY shares (3 lines, Form 4, code M).
Jul 1, 2026: Option exercises of PSTV shares (3 lines, Form 4, code M).
May 14, 2026: Grants or awards of PSTV derivative securities (2 lines, Form 4, code A).
Apr 1, 2026: Option exercises of PSTV shares (2 lines, Form 4, code M).
Feb 25, 2026: Grants or awards of PSTV derivative securities (2 lines, Form 4, code A).

Other insiders filing for CERENOME, INC. (CNSY)

van Es-Johansson An, Director
Hawkins Richard J, Director
Clowes Howard, Director
HEDRICK MARC H, Chief Executive Officer
ANDREWS RONALD ASBURY, Director
Guse Kyle, Director

How to read Form 4 transaction codes